Your trusted source for the latest news
A little more than five months after Pfizer discontinued development of its weight-loss drug known as danuglipron, the drugmaker announced its plan on Monday to acquire a biopharmaceutical company for close to $5 billion. Pfizer published a press release on Monday confirming the unanimous agreement ......
Source: The Blaze
Original URL: https://www.theblaze.com/news/pfizer-sets-sights-on-new-obesity-drug-market-in-multibillion-dollar-acquisition